NewTimeSpace News: August 17, 2026, CMS(00867.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 4.5 billion, increased by 12.46% YoY.
NewTimeSpace News: August 17, 2026, HAO WEN HLDGS(08019.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 24.63 million, increased by 12.66% YoY.
NewTimeSpace News: August 17, 2026, SKB BIO(06990.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 978.34 million, increased by 2.93% YoY.
NewTimeSpace News: August 17, 2026, TENFU(06868.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 624.47 million, decreased by 7.2% YoY.
August 17, 2026, WANGUO GOLD GP(03939.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 1.86 billion, increased by 50.23% YoY
August 17, 2026, TL NATURAL GAS(08536.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 40.74 million, decreased by 5% YoY
August 17, 2026, IMOTIONTECH(01274.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 760.5 million, increased by 107.79% YoY
NewTimeSpace News: August 17, 2026, CHUANGXIN IND(02788.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 11.53 billion, increased by 32.42% YoY.
NewTimeSpace News: SDHS NEW ENERGY (01250.HK) announced on 17 August 2026 that the profit attributable to equity holders of the Company for the six months ended 30 June 2026 is expected to be in the range of approximately RMB 139 million to RMB 170 million, compared with a profit attributable to shareholders of RMB 287 million for the same period of the previous year.
NewTimeSpace News: NEW VISION CO (02632.HK) announced on 16 August 2026 that the loss attributable to owners of the parent for the six months ended 30 June 2026 is expected to be in the range of approximately RMB 404 million to RMB 424 million.
NewTimeSpace News: On 17 August 2026, GOLDEN FAITH GP (02863.HK) announced that Tian Shisheng has been appointed as an Executive Director, effective 18 August 2026; Mr. Tian, aged 45, has over 20 years of experience in telecommunications, internet and finance, and previously served as Chairman of Zhengping Road & Bridge Construction (603843.SH), with an annual salary of HKD 3 million.
NewTimeSpace News: On 17 August 2026, SHANGHAI FUDAN (01385.HK) announced that it proposes to subscribe, as a limited partner, up to RMB 300 million in the Shanghai Rongsheng Industrial Innovation Fund (target size RMB 1.43 billion) initiated by Guosheng Capital, focusing on integrated circuits and aerospace; as Guosheng Investment proposes to acquire A-shares of the Company from Fuxin Fanga, the investment constitutes a connected transaction subject to shareholders' meeting approval.
NewTimeSpace News: On 17 August 2026, KONTA CHINA (01312.HK) announced that Executive Director and Chairman Wang Limin has resigned as President due to internal work arrangements (remaining as Chairman), and Li Qingshan has been appointed Executive Director and President, as well as a member of the Executive Committee and the Share Trading Committee, effective 17 August 2026.
NewTimeSpace News: On 18 August 2026, CANBRIDGE-B (01228.HK) announced that maralixibat oral solution has been approved by the National Health Insurance Administration of Taiwan, China for NHI coverage in treating both ALGS and PFIC, effective 1 September 2026. Maralixibat is the first approved drug for ALGS and PFIC in Taiwan, China, holding FDA Breakthrough Therapy designation and orphan drug designations across multiple jurisdictions. The company views the inclusion as an important milestone in its rare disease commercialization that will substantially reduce the financial burden on patient families.
NewTimeSpace News: On 17 August 2026, MOISELLE INT'L (00130.HK) announced that independent non-executive director Ng Lai Man has received a personal summons from the Magistrates' Court under the Magistrates Ordinance, relating to another licensed corporation in which she serves as a director and unrelated to the group; after assessment, the board considers the case will have no impact on the group's operations and financial position, and Ms. Ng remains an independent non-executive director.
NewTimeSpace News: On 17 August 2026, TATAHEALTH (01255.HK) issued an inside information announcement stating that former independent non-executive director Tao Zhiqiang had filed a winding-up petition against the company with the High Court of Hong Kong over unpaid director remuneration of HKD 139,150.68; no winding-up order has been made, and the hearing is scheduled for 21 October 2026. The board believes the matter can be resolved given the small claim amount, and the company is seeking legal advice and taking necessary measures.
